Viewing Study NCT00803192


Ignite Creation Date: 2025-12-24 @ 3:30 PM
Ignite Modification Date: 2026-02-25 @ 9:49 PM
Study NCT ID: NCT00803192
Status: COMPLETED
Last Update Posted: 2012-03-16
First Post: 2008-12-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed Conditions
Sponsor: Perrigo Company
Organization:

Study Overview

Official Title: Randomized, 2-Way Crossover, Bioequivalence Study of Famotidine 40 mg Tablets Administered as 1 x 40 mg Tablet in Healthy Subjects Under Fed Conditions
Status: COMPLETED
Status Verified Date: 2012-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Compare the rate and extent of absorption of famotidine 40 mg tablets, administered as 1 x 40 mg tablet under fed conditions.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: